Psilocybin Safety Study in Older Adults
Treatments studied
This research tests whether psilocybin (a psychoactive compound from certain mushrooms) is safe and well-tolerated in healthy people aged 65–85. Researchers want to understand how older adults respond to this substance and whether it could be useful for future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 65 and 85 years old
- Be in generally good health with no serious medical conditions
- Have a trusted support person (family member or friend) who can help during the study
- Not have a personal history of psychosis, schizophrenia, or serious bipolar disorder
- Not currently take medications that interact with psilocybin, including certain antidepressants or antipsychotics
- Not have active substance use disorder or recent heavy use of hallucinogenic drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a single dose of psilocybin (the active ingredient in magic mushrooms) affects brain structure in healthy older adults. You'll receive the drug in a safe setting and have brain scans before and after to see if it promotes positive changes.
This study tests if a single dose of psilocybin (a psychedelic) or dextromethorphan (a cough suppressant) can improve well-being in healthy older adults who feel their well-being is below average. It aims to understand how these drugs might help boost mood and life satisfaction.
This trial tests how the setting and context affect the experience of psilocybin, a psychedelic drug. It aims to understand how the environment influences the effects in healthy adults.
This trial tests whether psilocybin affects biological signs of aging and how much purpose you feel in life. If you are a healthy adult, you may qualify.
This early-stage research study tests how psilocybin (a naturally occurring compound from certain mushrooms) works when combined with a medication that blocks a specific serotonin pathway in the brain. Researchers want to understand how these two substances interact in healthy volunteers to inform future psychiatric treatment studies.
This study gives a single dose of psilocybin to healthy adults who are curious about psychedelics but have little to no past use. Researchers will measure how it affects your mood, brain activity, and body chemistry to understand its effects better.
Hear when a new Healthy Volunteer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.